| Name | Title | Contact Details |
|---|
Formerly known as Hip Sobriety, Inc., Tempest was founded in 2014 and is backed by Slow Ventures, Refactor, Female Founders Fund, and Red Light Management.
We are a vertically integrated cannabis company led by an industry-leading management team. In the United States, Jushi is focused on building a multi-state portfolio of branded cannabis assets through opportunistic acquisitions, distressed workouts and competitive applications. Jushi strives to maximize shareholder value while delivering high-quality products across all levels of the cannabis ecosystem.
Founded by Rachel Drori in 2015, Daily Harvest is on a mission to make nourishing, plant-based foods more attainable by eliminating barriers to access, cost, and time. With ready-in-minutes foods built on organic fruits and vegetables, Daily Harvest takes care of food so that food can take care of you. Since launching nationwide in 2016, Daily Harvest has become one of the fastest-growing direct-to-consumer brands today and was named one of Fast Company`s "World`s Most Innovative Companies" in 2018. In December 2017, Daily Harvest announced a Series B funding round of $43M led by Lightspeed Venture Partners and VMG Partners, and added Serena Williams and Bobby Flay to its roster of investors.
HUM is the first company to successfully bridge beauty and wellness, inviting everyone from everywhere to start within.
ChroMedX Corp. is a medical technology company focused on the development of novel, handheld medical devices for diagnostic testing at the patient`s bedside. HemoPalm, the Company`s lead product is the only handheld blood analysis system which combines Blood Gases & Electrolytes with full CO-oximetry. It has a single-use cartridge/handheld reader format, providing the simplest, most rapid and accurate testing process for use in management of critical care patients. Current blood gas systems require purchase of a second device to carry out CO-oximetry measurements. In addition, HemoPalm has the ability to draw capillary blood directly from pin-prick sites into the cartridge, as an alternative to the commonly required, risk-associated arterial blood draws. ChroMedX Corp. technologies are protected by the Company`s issued and pending patents, covering blood/plasma/serum collection, and processing and analysis.